Kerri Thomas, Ph.D.

Kerri Thomas, Ph.D. has a diverse range of work experience in the field of scientific research. Kerri is currently a Scientist II at Bonum Therapeutics, starting in September 2022. Prior to this, they worked as a Scientist at Good Therapeutics, Inc. from October 2021 to September 2022.

Kerri's academic background includes a role as an Immunology Graduate Student at the University of Washington, where they conducted their thesis research in the lab of Dr. David Rawlings at Seattle Children's Research Institute. Kerri'sresearch focused on studying IL-7R signaling pathway mutations and their impact on early B cell development and leukemogenesis. Kerri also developed genetically engineered mouse models of B cell acute lymphoblastic leukemia. Kerri'stime at the University of Washington spanned from August 2014 to July 2021.

Before their graduate studies, Kerri worked as a Research Technician II at the Benaroya Research Institute from September 2010 to August 2014. In this role, they provided general research support for an immunology lab and managed the lab's mouse colony. Kerri'smain research project involved investigating the role of the transcription factor Foxo1 in the regulation of CCR7 and CD62L expression in Treg subsets.

Kerri's earliest work experience was as an Undergraduate Researcher at Harvey Mudd College, where they conducted research on soft corals. Kerri sequenced the mitochondrial gene cytochrome b for various soft coral species and generated a phylogenetic tree from the data. Kerri determined that the gene region was not suitable for genetic distinction between soft coral families. This role lasted from May 2008 to August 2008.

Overall, Kerri Thomas, Ph.D. has demonstrated expertise and a strong research background in immunology, genetics, and molecular biology.

Kerri Thomas, Ph.D. completed their education in a chronological manner, starting with their Bachelor of Science (B.S.) degree in Molecular Biology from Harvey Mudd College. Kerri attended this college from 2005 to 2009. In 2008, they also had a brief exchange program at Universitat Pompeu Fabra, although no specific degree or field of study is mentioned for this time period. Later, they pursued their Doctor of Philosophy (Ph.D.) degree in Immunology at the University of Washington, from 2014 to 2021.